Skip to main content

Table 1 Patient characteristics (N = 31)

From: A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

 

Number of patients

%

Sex

 Male

24

77.4

 Female

7

22.6

ECOG PS

 0–1

27

87.1

 2

4

12.9

Clinical Stage

 IIIB

10

32.2

 IV

11

35.6

 Recurrence

10

32.2

Histological type

 Adenocarcinoma

16

51.6

 Squamous cell carcinoma

12

38.7

 Not specified

3

9.7

Smoking history

 Smoker

25

80.6

 Non-smoker

6

19.4

No. of prior treatment regimen

 1

14

45.1

 2

7

22.5

 3 or more

10

32.4

  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, PS performance status